Clinical Trial Update: An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP [Phase 1, Phase 2]

View source ↗

Summary

An efficacy study of IV boosting with ChAd63/MVA ME-TRAP for malaria completed its Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ChAd63-MVA ME-TRAP (ChAd63-MVA ME-TRAP viral vectored malaria vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED